Southend University Hospital NHS Foundation Trust

Population 338,800
Beds 762
Income £250,270k
Comprehensive Surplus £267k
Operating Surplus £5,032k
EBITDA 5.3%
PPI Cap 1.7%
PPI £633k
Public Members 5,968

In 2011/12 Monitor found the trust in breach of the terms of its authorisation [1]:

The decision was triggered by the Trust’s on going failure to meet cancer and C.Difficile targets and by CQC concerns which resulted in the Trust being red rated for governance by Monitor in the first quarter of 2011/12. Following a period of scrutiny, Monitor has found that the Trust does not have an effective system in place to proactively identify and address risks and also has concerns about the robustness of data which is being provided to the Board. Monitor has concluded that this is evidence of weak governance.

The trust treats private patients, but does not have a private patient unit [2].

In the Forward Plan [3] the trust says it wants to increase the contribution from charity and volunteers:

Increase charitable and other funds raised by 40%

See a 25% increase in the number of volunteer hours worked

The trust has a company called Enterprise Medical Ltd [4]:

Wholly owned by the Trust, the new company provides a commercial side to the Trustʼs existing Department of Innovation and develops ideas from hospital staff, that have commercial potential. Enterprise Medical also works with other NHS Trusts, private healthcare organisations, the academic sector, industry and individual inventors to help achieve commercial success for their innovations.

The company’s products involve endoscope gas sterilisation. The trust’s Director of HR and one NED are directors of Enterprise Medical Ltd. The Annual Report [5] says that the trust has invested £300,000 in the company, and in addition:

The company did not trade during the current financial year. The company entered into a asset financing agreement in March 2012 which has a value of £2.2m, of which Southend NHS Foundation Trust has provided a parent company guarantee of £1.5m, but no funds have been transferred during the financial year. No material transactions have occurred in the current financial year, and as a result its results have not been consolidated in these financial statements.

The trust sees AQP as a threat:

There is the potential for new forms of competition from both within and outside the NHS – niche providers or new forms of community-based care. Whilst this is not well developed in [South East Essex] at present the Trust will continually review the market to assess any changes that could potentially affect the hospital. This is likely to present a greater risk as the ‘Any Qualified Provider’ regulations take hold.

The trust also sees some opportunities in AQP.

Site Map
Up: Trust profiles


[1] www.monitor-nhsft.gov.uk/home/news-events-and-publications/latest-press-releases/press-release-archive/2011/monitor-finds-sou
[2] www.southend.nhs.uk/for-patients-visitors/private-patients/
[3] www.monitor-nhsft.gov.uk/sites/all/modules/fckeditor/plugins/ktbrowser/_openTKFile.php?id=10851
[4] www.enterprisemedical.co.uk/index.php
[5] www.monitor-nhsft.gov.uk/sites/all/modules/fckeditor/plugins/ktbrowser/_openTKFile.php?id=14381